公司概覽
業務類別 Biotechnology
業務概覽 Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.
公司地址 230 E Grand Avenue, Suite S-100, South San Francisco, CA, USA, 94080
電話號碼 +1 888 743-2290
傳真號碼 --
公司網頁 https://www.electra-therapeutics.com
員工數量 46
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Quehuong Dong, M.B.A. Director, President and Chief Executive Officer -- 28/08/2026
Mr. Chris Clark, C.F.A. Chief Financial Officer -- 28/08/2026
Dr. Kim-Hien Dao, PhD Chief Medical Officer -- 28/08/2026
Dr. Gary S. Koe, PhD Chief Technical Officer -- 28/08/2026
Dr. Graham Parry, PhD Chief Scientific Officer -- 28/08/2026
 
董事會成員
董事會 職務 更新日期
Dr. Beth C. Seidenberg,M.D. Independent Director 28/08/2026
Dr. Carl L. Gordon, C.F.A.,PhD Independent Director 28/08/2026
Mr. Matthew K. Fust, M.B.A. Independent Director 28/08/2026
Dr. Nancy E. Stagliano, PhD Chairman of the Board 28/08/2026
Ms. Quehuong Dong, M.B.A. Director, President and Chief Executive Officer 28/08/2026
Dr. Thomas Geninatti, PhD Independent Director 28/08/2026
 
所屬ETF (更新日期: 03/10/2026 04:56)
代號 名稱 佔比% ▼ 持有日期
TMEDT. Rowe Price Health Care ETF0.01%30/09/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.